AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
CHANGES IN HORMONAL RECEPTOR EXPRESSION AND PROLIFERATIVE FEATURES INLOCALLY RELAPSED BREAST-CANCER PATIENTS (BCP)
Authors: MUNOZ M MALLOFRE C SOLER G MARTINRICHARD M MONTANER J FARRUS B FERNANDEZ PL PAHISA J FONTANILLAS M ESTAPE J
Citation: M. Munoz et al., CHANGES IN HORMONAL RECEPTOR EXPRESSION AND PROLIFERATIVE FEATURES INLOCALLY RELAPSED BREAST-CANCER PATIENTS (BCP), Annals of oncology, 9, 1998, pp. 72-72
RANDOMIZED ADJUVANT MITOMYCIN VERSUS ABSTENTION IN RESECTED GASTRIC-CANCER - RESULTS AFTER 17-YEAR FOLLOW-UP
Authors: GRAU JJ ESTAPE J ALBIOL S
Citation: Jj. Grau et al., RANDOMIZED ADJUVANT MITOMYCIN VERSUS ABSTENTION IN RESECTED GASTRIC-CANCER - RESULTS AFTER 17-YEAR FOLLOW-UP, Annals of oncology, 9, 1998, pp. 218-218
UFT ACTIVITY IN ADVANCED RENAL-CARCINOMA (RCA)
Authors: DANIELS M MELLADO B MARTIN W ALBIOL S GALAN MC CASAS F CARRETERO P ESTAPE J
Citation: M. Daniels et al., UFT ACTIVITY IN ADVANCED RENAL-CARCINOMA (RCA), Annals of oncology, 9, 1998, pp. 284-284
CONCURRENT CISPLATIN AND ETOPOSIDE PLUS CHEST HYPERFRACTIONATED RADIOTHERAPY (RT) FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC) - PILOT-STUDY
Authors: VINOLAS N CASAS F GIMFERRER JM AGUSTI C DANIELS M SOLER G BIETE A ESTAPE J
Citation: N. Vinolas et al., CONCURRENT CISPLATIN AND ETOPOSIDE PLUS CHEST HYPERFRACTIONATED RADIOTHERAPY (RT) FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC) - PILOT-STUDY, Annals of oncology, 9, 1998, pp. 508-508
DETECTION OF OCCULT BREAST-CANCER CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION (RT-PCR) - ROLE OF SURGICAL MANIPULATION
Authors: GALAN MC VINOLAS N COLOMER D MUNOZ M LOPEZGUERRERO JA SOLER G ESTAPE J
Citation: Mc. Galan et al., DETECTION OF OCCULT BREAST-CANCER CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION (RT-PCR) - ROLE OF SURGICAL MANIPULATION, Annals of oncology, 9, 1998, pp. 582-582
MAINTENANCE TREATMENT WITH INTERFERON-ALPHA-2B IN MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED STUDY FROM PETHEMA (PROGRAM FOR THE STUDY ANDTREATMENT OF HEMATOLOGICAL MALIGNANCIES, SPANISH-SOCIETY-OF-HEMATOLOGY)
Authors: BLADE J SANMIGUEL JF ESCUDERO ML FONTANILLAS M BESALDUCH J GARDELLA S ARIAS J GARCIACONDE J CARNERO M MARTI JM ROZMAN C ESTAPE J MONTSERRAT E
Citation: J. Blade et al., MAINTENANCE TREATMENT WITH INTERFERON-ALPHA-2B IN MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED STUDY FROM PETHEMA (PROGRAM FOR THE STUDY ANDTREATMENT OF HEMATOLOGICAL MALIGNANCIES, SPANISH-SOCIETY-OF-HEMATOLOGY), Leukemia, 12(7), 1998, pp. 1144-1148
RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MITOMYCIN PLUS FTORAFUR VERSUS MITOMYCIN ALONE IN RESECTED LOCALLY ADVANCED GASTRIC-CANCER
Authors: GRAU JJ ESTAPE J FUSTER J FILELLA X VISA J TERES J SOLER G ALBIOL S GARCIAVALDECASAS JC GRANDE L BOMBI J BORDAS J ALCOBENDOS F
Citation: Jj. Grau et al., RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MITOMYCIN PLUS FTORAFUR VERSUS MITOMYCIN ALONE IN RESECTED LOCALLY ADVANCED GASTRIC-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 1036-1039
TUMOR-MARKERS IN RESPONSE MONITORING AND PROGNOSIS OF NONSMALL CELL LUNG-CANCER - PRELIMINARY-REPORT
Authors: VINOLAS N MOLINA R GALAN MC CASAS F CALLEJAS MA FILELLA X GRAU JJ BALLESTA AM ESTAPE J
Citation: N. Vinolas et al., TUMOR-MARKERS IN RESPONSE MONITORING AND PROGNOSIS OF NONSMALL CELL LUNG-CANCER - PRELIMINARY-REPORT, Anticancer research, 18(1B), 1998, pp. 631-634
PROGNOSTIC FACTORS IN UTERINE SARCOMAS - RETROSPECTIVE STUDY OF 21 YEARS AT THE HOSPITAL-CLINIC-I-PROVINCIAL OF BARCELONA
Authors: ROVIROSA A ORDI J ASCASO C CASALS J LEJARCEGUI A IGLESIAS J ESTAPE J BIETE A
Citation: A. Rovirosa et al., PROGNOSTIC FACTORS IN UTERINE SARCOMAS - RETROSPECTIVE STUDY OF 21 YEARS AT THE HOSPITAL-CLINIC-I-PROVINCIAL OF BARCELONA, Medicina Clinica, 111(5), 1998, pp. 172-176
P21(WAF1 CIP1) IS ASSOCIATED WITH CYCLIN D1(CCND1) EXPRESSION AND TUBULAR DIFFERENTIATION BUT IS INDEPENDENT OF P53 OVEREXPRESSION IN HUMANBREAST-CARCINOMA/
Authors: REY MJ FERNANDEZ PL JARES P MUNOZ M NADAL A PEIRO N NAYACH I MALLOFRE C MUNTANE J CAMPO E ESTAPE J CARDESA A
Citation: Mj. Rey et al., P21(WAF1 CIP1) IS ASSOCIATED WITH CYCLIN D1(CCND1) EXPRESSION AND TUBULAR DIFFERENTIATION BUT IS INDEPENDENT OF P53 OVEREXPRESSION IN HUMANBREAST-CARCINOMA/, Journal of pathology, 184(3), 1998, pp. 265-271
OUTCOME OF PATIENTS AFTER CURATIVE RESECTION OF PULMONARY METASTASES
Authors: CALLEJAS MA GRAU JJ BELDA X GIMFERRER JM CANALIS E CATALAN M SANCHEZLLORET J ESTAPE J
Citation: Ma. Callejas et al., OUTCOME OF PATIENTS AFTER CURATIVE RESECTION OF PULMONARY METASTASES, International surgery, 83(1), 1998, pp. 8-10
THE VALUE OF POSTOPERATIVE SURVEILLANCE AFTER RADICAL SURGERY FOR COLORECTAL-CANCER
Authors: DANIELS M BESSA X CASTELLS A ALBIOL S VINOLAS N PIQUE JM TERES J ESTAPE J
Citation: M. Daniels et al., THE VALUE OF POSTOPERATIVE SURVEILLANCE AFTER RADICAL SURGERY FOR COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 739-739
PHASE-II TRIAL OF CISPLATINUM AND ETOPOSIDE IN BRAIN METASTASES OF SOLID TUMORS
Authors: VINOLAS N GRAUS F MELLADO B CARALT L ESTAPE J
Citation: N. Vinolas et al., PHASE-II TRIAL OF CISPLATINUM AND ETOPOSIDE IN BRAIN METASTASES OF SOLID TUMORS, Journal of neuro-oncology, 35(2), 1997, pp. 145-148
FOLLOW-UP-STUDY IN HEAD AND NECK-CANCER - CURE RATE ACCORDING TO TUMOR LOCATION AND STAGE
Authors: GRAU JJ CUCHI A TRASERRA J FIRVIDA JL ARIAS C BLANCH JL ESTAPE J
Citation: Jj. Grau et al., FOLLOW-UP-STUDY IN HEAD AND NECK-CANCER - CURE RATE ACCORDING TO TUMOR LOCATION AND STAGE, Oncology, 54(1), 1997, pp. 38-42
P21(WAF1 C1P1) EXPRESSION IS ASSOCIATED WITH CYCLIN D1 BUT NOT P53 EXPRESSION IN BREAST-CARCINOMA, AND CORRELATES WITH INCREASED PROLIFERATIVE ACTIVITY/
Authors: FERNANDEZ PL REY MJ JARES P CAMPO E MUNOZ M FONTANILLAS M MALLOFRE C MUNTANE J NAYACH I PEIRO N ESTAPE J CARDESA A
Citation: Pl. Fernandez et al., P21(WAF1 C1P1) EXPRESSION IS ASSOCIATED WITH CYCLIN D1 BUT NOT P53 EXPRESSION IN BREAST-CARCINOMA, AND CORRELATES WITH INCREASED PROLIFERATIVE ACTIVITY/, Laboratory investigation, 76(1), 1997, pp. 85-85
CYCLIN D1 AND RETINOBLASTOMA GENE-EXPRESSION IN HUMAN BREAST-CARCINOMA - CORRELATION WITH TUMOR PROLIFERATION AND ESTROGEN-RECEPTOR STATUS
Authors: JARES P REY MJ FERNANDEZ PL CAMPO E NADAL A MUNOZ M MALLOFRE C MUNTANE J NAYACH I ESTAPE J CARDESA A
Citation: P. Jares et al., CYCLIN D1 AND RETINOBLASTOMA GENE-EXPRESSION IN HUMAN BREAST-CARCINOMA - CORRELATION WITH TUMOR PROLIFERATION AND ESTROGEN-RECEPTOR STATUS, Journal of pathology, 182(2), 1997, pp. 160-166
IMMUNOHISTOCHEMICAL STUDY OF ALPHA-CLASS, MU-CLASS AND PI-CLASS GLUTATHIONE-S-TRANSFERASE EXPRESSION IN MALIGNANT-MELANOMA
Authors: MORAL A PALOU J LAFUENTE A MOLINA R PIULACHS J CASTEL T TRIAS M MASCARO JM VILALTA A BALLESTA A MOLINA T ESTIVILL X ESTAPE J
Citation: A. Moral et al., IMMUNOHISTOCHEMICAL STUDY OF ALPHA-CLASS, MU-CLASS AND PI-CLASS GLUTATHIONE-S-TRANSFERASE EXPRESSION IN MALIGNANT-MELANOMA, British journal of dermatology, 136(3), 1997, pp. 345-350
GLUTATHIONE-S-TRANSFERASE M1 AND CODON-72 P53 POLYMORPHISMS IN A NORTHWESTERN MEDITERRANEAN POPULATION AND THEIR RELATION TO LUNG-CANCER SUSCEPTIBILITY
Authors: TOFIGUERAS J GENE M GOMEZCATALAN J GALAN C FIRVIDA J FUENTES M RODAMILANS M HUGUET E ESTAPE J CORBELLA J
Citation: J. Tofigueras et al., GLUTATHIONE-S-TRANSFERASE M1 AND CODON-72 P53 POLYMORPHISMS IN A NORTHWESTERN MEDITERRANEAN POPULATION AND THEIR RELATION TO LUNG-CANCER SUSCEPTIBILITY, Cancer epidemiology, biomarkers & prevention, 5(5), 1996, pp. 337-342
NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN THE MULTIDISCIPLINARY TREATMENT OF ORAL-CANCER STAGE-III OR STAGE-IV
Authors: GRAU JJ ESTAPE J BLANCH JL VILALTA A CASTRO V BIETE A DANIELS M
Citation: Jj. Grau et al., NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN THE MULTIDISCIPLINARY TREATMENT OF ORAL-CANCER STAGE-III OR STAGE-IV, European journal of cancer. Part B, Oral oncology, 32B(4), 1996, pp. 238-241
CHOP VS PROMACE-CYTABOM IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: MONTSERRAT E GARCIACONDE J VINOLAS H LOPEZGUILLERMO A HERNANDEZNIETO L ZUBIZARRETA A MALDONADO J ALCALA A FAURA MV LLORENTE A BLADE J FONTANILLAS M ESTAPE J ROZMAN C GONZALEZBRITO C CONDE E PASCUAL A SANCHEZMANZANO C GIRAL M MORO MJ RAMOS F MACROVERA J
Citation: E. Montserrat et al., CHOP VS PROMACE-CYTABOM IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of haematology, 57(5), 1996, pp. 377-383
DETECTION OF CIRCULATING NEOPLASTIC-CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION IN MALIGNANT-MELANOMA - ASSOCIATION WITH CLINICAL STAGE AND PROGNOSIS
Authors: MELLADO B COLOMER D CASTEL T MUNOZ M CARBALLO E GALAN M MASCARO JM VIVESCORRONS JL GRAU JJ ESTAPE J
Citation: B. Mellado et al., DETECTION OF CIRCULATING NEOPLASTIC-CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION IN MALIGNANT-MELANOMA - ASSOCIATION WITH CLINICAL STAGE AND PROGNOSIS, Journal of clinical oncology, 14(7), 1996, pp. 2091-2097
SURVIVAL OF MULTIPLE-MYELOMA PATIENTS WHO ARE POTENTIAL CANDIDATES FOR EARLY HIGH-DOSE THERAPY INTENSIFICATION AUTOTRANSPLANTATION AND WHO WERE CONVENTIONALLY TREATED/
Authors: BLADE J SANMIGUEL JF FONTANILLAS M ALCALA A MALDONADO J GARCIACONDE J CONDE E CONZALEZBRITO G MORO MJ ESCUDERO ML TRUJILLO J PASCUAL A ROZMAN C ESTAPE J MONTSERRAT E
Citation: J. Blade et al., SURVIVAL OF MULTIPLE-MYELOMA PATIENTS WHO ARE POTENTIAL CANDIDATES FOR EARLY HIGH-DOSE THERAPY INTENSIFICATION AUTOTRANSPLANTATION AND WHO WERE CONVENTIONALLY TREATED/, Journal of clinical oncology, 14(7), 1996, pp. 2167-2173
6-YEAR FOLLOW-UP OF PRIMARY SMALL-CELL CARCINOMA OF THE ESOPHAGUS SHOWING A COMPLETE RESPONSE - A CASE-REPORT
Authors: CASAS F FARRUS B DANIELS M REYES MJ CAMPO E ESTAPE J BIETE A
Citation: F. Casas et al., 6-YEAR FOLLOW-UP OF PRIMARY SMALL-CELL CARCINOMA OF THE ESOPHAGUS SHOWING A COMPLETE RESPONSE - A CASE-REPORT, Japanese Journal of Clinical Oncology, 26(3), 1996, pp. 180-184
CALCIUM SUPPLEMENTATION AND OTOTOXICITY IN PATIENTS RECEIVING CISPLATIN
Authors: GRAU JJ ESTAPE J CUCHI MA FIRVIDA JL BLANCH JL ASCASO C
Citation: Jj. Grau et al., CALCIUM SUPPLEMENTATION AND OTOTOXICITY IN PATIENTS RECEIVING CISPLATIN, British journal of clinical pharmacology, 42(2), 1996, pp. 233-235
SURVIVAL AFTER CHEMOTHERAPY WITH CISPLATIN AND INFUSION OF BLEOMYCIN PRIOR TO LOCAL-REGIONAL TREATMENT IN PYRIFORM SINUS CANCER
Authors: GRAU JJ CUCHI A ESTAPE J ARIAS C MANE JM FIRVIDA JL MORENO F TRASERRA J
Citation: Jj. Grau et al., SURVIVAL AFTER CHEMOTHERAPY WITH CISPLATIN AND INFUSION OF BLEOMYCIN PRIOR TO LOCAL-REGIONAL TREATMENT IN PYRIFORM SINUS CANCER, Tumori, 82(3), 1996, pp. 221-224
Risultati: 1-25 | 26-45